Shield Therapeutics (GB:STX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shield Therapeutics is set to raise $10 million through a share subscription agreement with AOP Health, contingent on shareholder approval, which would grant AOP a controlling stake. Additionally, the company plans a RetailBook Offer to raise up to £1 million from existing retail shareholders. This financial maneuver is crucial for Shield’s goal of becoming cash flow positive by the end of 2025.
For further insights into GB:STX stock, check out TipRanks’ Stock Analysis page.